#United States #San Diego #Robbins LLP #Securities Class Action #PROCEPT BioRobotics

Securities Class Action Overview

Robbins LLP, a leading shareholder rights law firm, has brought attention to a class action lawsuit filed on behalf of shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT). This lawsuit is pertinent to all individuals who purchased the company's common stock between February 28, 2024, and February 25, 2026. Investors who suffered significant losses during this period should act swiftly to understand their legal options before the September 22, 2026 deadline to apply as a lead plaintiff.

Allegations Against PROCEPT

The lawsuit centers on various allegations of misleading practices undertaken by PROCEPT regarding its business operations and financial health. Key points include:

1. Misleading Statements: The corporation allegedly made false or misleading statements about its activities, operations, and financial status during the class period, negatively affecting its stock price and investors' holdings.
2. Discount Programs: It was reported that PROCEPT employed an extensive discount strategy to entice customers to drastically increase orders, which distorted the actual demand for their products. This tactic is said to have inflated reported sales figures, giving a false impression of the business's performance.
3. Customer Orders Exceeding Demand: Throughout the lawsuit's timeframe, the substantial gap between customer orders and actual medical procedures indicated an artificial increase in product orders, leading to an overstock situation, which significantly impacted the company's inventory management and credibility.
4. Financial Guidance Issues: PROCEPT had to ultimately retract its sales guidance for 2025 due to these discrepancies, further eroding investor trust.

Impact of Earnings Announcements

The financial disclosures from PROCEPT during the second half of 2025 revealed troubling declines in headpiece unit shipments. Following these announcements, the stock price witnessed alarming drops:

• - On August 6, 2025, the poor performance in unit shipments resulted in revising downwards the upcoming earnings forecasts.
• - Further announcements on November 4 and February 25 showed continuing sales failures and financial miscalculations which contributed to investor losses, with the stock plummeting by over 18% in just two days.

By February 2026, the firm's efforts to address its inventory issues and the fallout from undisclosed discount practices had disgraced investor confidence, pushing the share price below $18.

Class Action Participation

Investors who acquired PROCEPT securities from February 28, 2024, to February 25, 2026, may be eligible to participate in this class action lawsuit. Legal representation through Robbins LLP is offered on a contingency basis, ensuring no upfront payment for those who opt to participate.

What is a Lead Plaintiff?

The role of lead plaintiff is to represent all affected investors throughout the legal proceedings. Although participation offers recourse for financial recovery, it is not mandatory for injured investors to hold this title to benefit from the case’s outcome. The deadline to seek lead plaintiff status is September 22, 2026.

Contacting Robbins LLP

For investors impacted by these developments and wishing to explore their legal rights, Robbins LLP encourages immediate contact for further insights into the class action process. Interested parties can reach out via email to attorney Aaron Dumas, Jr. or by calling (800) 350-6003.

About Robbins LLP

Robbins LLP specializes in securities fraud litigation and has been instrumental in recovering over $1 billion for investors over the years. The firm is dedicated to ensuring corporations maintain transparency and accountability to their shareholders, a principle emphasized by founder Brian J. Robbins.

For updates on the progress of this class action and other information related to corporate wrongdoing, investors can sign up for the firm’s Stock Watch notifications.

Attorney Advertising - Previous settlements do not guarantee similar outcomes in the future.